Hepatology Highlights

Joseph F. Pisa, Robert S. Brown, Lauren M. Yang, Daryl T.Y. Lau, Brett E. Fortune, Sayed Obaidullah Aseem, Robert E. Schwartz, Nicholas Russo, Vikas Gupta, Muhammad Amir, Giorgio Roccaro, Nidhi Jalan‐Sakrikar, Enis Kostallari, Amaia Navarro‐Corcuera – 29 November 2019

The North American Consortium for the Study of End‐Stage Liver Disease–Acute‐on‐Chronic Liver Failure Score Accurately Predicts Survival: An External Validation Using a National Cohort

Russell Rosenblatt, Nicole Shen, Zaid Tafesh, Shirley Cohen‐Mekelburg, Carl V. Crawford, Sonal Kumar, Catherine Lucero, Robert S. Brown, Arun Jesudian, Brett E. Fortune – 29 November 2019 – Acute‐on‐chronic liver failure (ACLF) carries high short‐term mortality. The North American Consortium for the Study of End‐Stage Liver Disease (NACSELD)–ACLF score, positive if ≥2 organ failures are present, is a bedside tool that predicts short‐term mortality in patients with cirrhosis.

An Open‐Label, Dose‐Escalation Study to Assess the Safety and Efficacy of IL‐22 Agonist F‐652 in Patients With Alcohol‐associated Hepatitis

Juan P. Arab, Tejasav S. Sehrawat, Douglas A. Simonetto, Vikas K. Verma, Dechun Feng, Tom Tang, Kevin Dreyer, Xiaoqiang Yan, William L. Daley, Arun Sanyal, Naga Chalasani, Svetlana Radaeva, Liu Yang, Hugo Vargas, Mauricio Ibacache, Bin Gao, Gregory J. Gores, Harmeet Malhi, Patrick S. Kamath, Vijay H. Shah – 27 November 2019

Subscribe to